Notification of Nontuberculous Mycobacteria: An Australian Perspective.
Rachel M ThomsonEllen DonnanAnastasios KonstantinosPublished in: Annals of the American Thoracic Society (2018)
In Queensland, Australia, all cases of mycobacterial infection (tuberculosis [TB] and nontuberculous mycobacteria [NTM]) are notifiable under the Queensland Public Health Act (2005). This process originally emerged to avoid NTM confounding with notification of cases of TB, but has facilitated awareness of the increasing incidence and changing epidemiology of NTM. Although initially not a public health priority, the notification process has facilitated research that has led to an appreciation of both public health and environmental health issues associated with these pathogens. When reports of NTM infections were low in frequency, reporting was managed largely by clinicians specializing in TB. However, as reports of NTM isolates surpassed those for TB, the workload associated with clinical reporting exceeded resources. The Communicable Diseases Branch transitioned to digital reporting of laboratory isolates of mycobacteria, thereby enabling weekly and quarterly reporting of data, and generation of more detailed annual reports. The reports now include species and geographic distributions by health service district, allowing identification of clusters requiring further investigation and systematic reviews of different species. With ecological and climate change, the distribution and virulence of these emerging pathogens are evolving. Evidence of transmission of highly virulent and antibiotic-resistant clones of Mycobacterium abscessus among patients with cystic fibrosis internationally heightens the need for timely reporting to public health authorities. Ongoing systematic monitoring by public health authorities will be crucial to our understanding of NTM diseases.
Keyphrases
- public health
- adverse drug
- mycobacterium tuberculosis
- climate change
- electronic health record
- global health
- genetic diversity
- human health
- emergency department
- systematic review
- healthcare
- risk factors
- escherichia coli
- pulmonary tuberculosis
- staphylococcus aureus
- drug induced
- gram negative
- palliative care
- hepatitis c virus
- risk assessment
- randomized controlled trial
- hiv aids
- cystic fibrosis
- social media
- biofilm formation